FR
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Utility of the Amygdalar Atrophy Scale to Identify Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Memory Clinic | Neurology |  | 2026 | 1 | 0 | ||
| Subjective Cognitive Decline, Inter‐Personal Attachment Style and Relationship Quality | Journal of general and family medicine | | 2025 | 16 | 105 | ||
| Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease | Neurology | | 2025 | 14 | 163 | ||
| Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer’s disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET | European journal of nuclear medicine and molecular imaging | | 2025 | 16 | 103 | ||
| Resilience in Alzheimer's disease: Impact of operationalization and methodological choices | Alzheimer's & dementia | | 2025 | 127 | 237 | ||
| Exploring the dimensionality of a neuropsychological test battery in a memory clinic setting using psychometric network analysis | 18th Conference of the Swiss Psychological Society |  | 2025 | 21 | 1 | ||
| Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment | European journal of nuclear medicine and molecular imaging | | 2025 | 18 | 343 | ||
| Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline | Brain | | 2024 | 9 | 118 | ||
| Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort | Journal of neurology | | 2024 | 116 | 52 | ||
| A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | | 2024 | 89 | 74 | ||
| Fingerprints of brain disease : connectome identifiability in Alzheimer's disease | Communications biology | | 2024 | 204 | 83 | ||
| Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients | Alzheimer's research & therapy | | 2024 | 155 | 161 | ||
| Insights into single-timepoint ASL hemodynamics: what visual assessment and spatial coefficient of variation can tell | La Radiologia medica | | 2024 | 77 | 52 | ||
| Alterations in gamma frequency oscillations correlate with cortical tau deposition in Alzheimer’s disease | Neurobiology of aging | | 2024 | 124 | 168 | ||
| The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline | Alzheimer's & dementia | | 2024 | 130 | 158 | ||
| Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer's disease | European journal of nuclear medicine and molecular imaging | | 2023 | 84 | 288 | ||
| Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic | Journal of neurology, neurosurgery and psychiatry | | 2023 | 266 | 204 | ||
| Prognostic value of imaging-based ATN profiles in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | | 2023 | 99 | 105 | ||
| Analysis of psychological symptoms following disclosure of amyloid-positron emission tomography imaging results to adults with subjective cognitive decline | JAMA network open | | 2023 | 94 | 113 | ||
| Patterns of amyloid accumulation in amyloid-negative cases | Neurobiology of aging | | 2023 | 78 | 31 | ||
| ATN profile classification across two independent prospective cohorts | Frontiers in medicine | | 2023 | 138 | 134 | ||
| Dementia prevention in memory clinics : recommendations from the european task force for brain health services | The Lancet regional health. Europe | | 2023 | 119 | 211 | ||
| Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting | The Journal of nuclear medicine | | 2023 | 179 | 273 | ||
| Exploring the structure of a neuropsychological assessment with cognitively healthy adults | 17 th Conference of the Swiss Psychological Society | | 2022 | 187 | 8 | ||
| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised | Nature reviews. Neuroscience | | 2022 | 167 | 1 | ||
| Simulad: a dynamical model for personalized simulation and disease staging in alzheimer's disease | Neurobiology of aging | | 2022 | 136 | 62 | ||
| The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging | Journal of Alzheimer's disease | | 2022 | 214 | 145 | ||
| Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study | Magnetic resonance imaging | | 2021 | 109 | 0 | ||
| Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6 | Alzheimer's research & therapy | | 2021 | 186 | 341 | ||
| Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison | European Journal of Nuclear Medicine and Molecular Imaging | | 2021 | 344 | 227 | ||
| Brain connectivity and metacognition in persons with subjective cognitive decline (COSCODE): rationale and study design | Alzheimer's Research and Therapy | | 2021 | 447 | 405 | ||
| Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6 | Alzheimer's research & therapy | | 2021 | 225 | 282 | ||
| Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services — part 2 of 6 | Alzheimer's research & therapy | | 2021 | 162 | 271 | ||
| Protocols for cognitive enhancement. a user manual for brain health services — part 5 of 6 | Alzheimer's research & therapy | | 2021 | 161 | 197 | ||
| Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome | Journal of Alzheimer's disease | | 2021 | 216 | 0 | ||
| Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services — part 6 of 6 | Alzheimer's research & therapy | | 2021 | 129 | 147 | ||
| Dementia risk communication. A user manual for Brain Health Services — part 3 of 6 | Alzheimer's research & therapy | | 2021 | 137 | 210 | ||
| Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study | Aging Clinical and Experimental Research | | 2020 | 457 | 1 | ||
| CSF cutoffs for MCI due to AD depend on APOEε4 carrier status | Neurobiology of Aging | | 2020 | 294 | 2 | ||
| Comparison of Bioinformatics Pipelines and Operating Systems for the Analyses of 16S rRNA Gene Amplicon Sequences in Human Fecal Samples | Frontiers in Microbiology | | 2020 | 446 | 244 | ||
| The A/T/N model applied through imaging biomarkers in a memory clinic | European Journal of Nuclear Medicine and Molecular Imaging | | 2019 | 425 | 6 | ||
| Is a large-scale screening for Alzheimer's disease possible? yes, in a few years | The Journal of Prevention of Alzheimer's Disease | | 2019 | 309 | 7 |
